Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges
Cells · 06.05.2025 · 14 (9) · 675
DOI: 10.3390/cells14090675 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 06.05.2025. Verfasst von Asma Mahdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Education City, Doha P.O. Box 5825, Qatar. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Glioma, Brain Neoplasms, Glioblastoma. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamad Bin Khalifa University, Qatar National Research Fund, Foundation against Cancer.
Abstract (Originalsprache)
Glioblastoma (GBM), or grade 4 glioma, is the most common and aggressive primary brain tumor in adults with a median survival of 15 months. Increasing evidence suggests that GBM’s aggressiveness, invasiveness, and therapy resistance are driven by glioma stem cells (GSCs), a subpopulation of tumor cells that share molecular and functional characteristics with neural stem cells (NSCs). GSCs are heterogeneous and highly plastic. They evade conventional treatments by shifting their state and entering in quiescence, where they become metabolically inactive and resistant to radiotherapy and chemotherapy. GSCs can exit quiescence and be reactivated to divide into highly proliferative tumor cells which contributes to recurrence. Understanding the molecular mechanisms regulating the biology of GSCs, their plasticity, and the switch between quiescence and mitotic activity is essential to shape new therapeutic strategies. This review examines the latest evidence on GSC biology, their role in glioblastoma progression and recurrence, emerging therapeutic approaches aimed at disrupting their proliferation and survival, and the mechanisms underlying their resistance to therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Education City, Doha P.O. Box 5825, Qatar.
ORCID-Profile: Mohamed Aittaleb, Fadel Tissir
Förderung
- Hamad Bin Khalifa University
- Qatar National Research Fund
- Foundation against Cancer
Zitieren
APA
Mahdi, A., Aittaleb, M., & Tissir, F. (2025). Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges. Cells, 14(9), 675. https://doi.org/10.3390/cells14090675
Vancouver
Mahdi A, Aittaleb M, Tissir F. Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges. Cells. 2025;14(9):675. doi:10.3390/cells14090675
BibTeX
@article{Mahdi2025,
author = {Mahdi, Asma and Aittaleb, Mohamed and Tissir, Fadel},
title = {Targeting Glioma Stem Cells: Therapeutic Opportunities and Challenges},
journal = {Cells},
year = {2025},
volume = {14},
number = {9},
pages = {675},
doi = {10.3390/cells14090675}
}
EUVIMED